Experts warn that popular eyelash extensions can trigger severe eye condition

Health experts have warned that eyelash extensions - a popular beauty treatment used to lengthen and thicken natural lashes - could lead to serious eye problems.

Itchy eyes? Experts reveal the causes and what you can do about them

Dry eyes are also a common source of itch - the result of hormonal changes related to aging, taking certain medications, some ...

LEO Pharma to Present 17 Scientific Abstracts at AAD 2026 Highlighting Real--World Evidence, Long--Term Outcomes and Patient Experience Across Multiple Dermatological Conditions

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 17 scientific posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting (March 27-31, Denver, ...

Miracle new treatment to REVERSE male hair loss that's 50 times cheaper than a transplant. You don't have to fly to Turkey or Thailand... and can do it on your lunch …

Two in every five Americans have named hair loss as their most-feared physical change when thinking about aging, according to ...
The Independent on MSN

Itchy eyes? Experts reveal the causes and how to get relief

Itchy eyes? Experts reveal the causes and what you can do about them - Some 22 million Americans suffer from eye allergies ...
Everyday Health on MSN

My eyes get itchier every spring, but I’ve found the solution

Spring allergies can cause eyes to get itchy, red, and swollen. Our writer found five doctor-recommended solutions without a prescription.
PolitiFact

Social media is trying to sell you on lymphatic drainage massage. Is that really something you need?

The lymphatic system is part of the human immune system. It’s a collection of tissues and vessels that move a fluid called lymph throughout the body. A lymphatic drainage massag ...

Lilly's EBGLYSS (lebrikizumab-lbkz) is the first and only selective IL-13 inhibitor to deliver positive Phase 3 outcomes in patients aged six months to 18 years with moderate ...

Eli Lilly and Company (NYSE: LLY) today announced positive, topline results from the Phase 3 ADorable-1 trial evaluating the safety and efficacy of EBGLYSS (lebrikizumab-lbkz) in pediatric patients ...
The Del Norte Triplicate

Federation And It Spit Him Out Very Cute House Paper Inside Of Shaft

Federation And It Spit Him Out Very Cute House Paper Inside Of Shaft. Disappointing balcony view! Afterwards start it today! Wednesday what time? Second story to publication. No d ...